T1	intervention 23 38	Calendula cream
T2	control 43 56	aqueous cream
T3	condition 78 108	acute radiation skin reactions
T4	outcome-Measure 440 486	difference in proportion of patients with ARSR
T9	total-participants 976 979	420
T10	total-participants 1009 1012	411
T12	iv-bin-percent 1247 1250	23%
T13	intervention-participants 1256 1258	45
T14	cv-bin-percent 1287 1290	19%
T15	control-participants 1296 1298	38
T16	intervention 241 263	Calendula Weleda cream
T17	intervention 268 279	Essex cream
T18	outcome 1431 1462	levels of skin related symptoms
T11	outcome 1346 1357	severe ARSR
T19	outcome 1173 1197	incidence of severe ARSR
T5	outcome-Measure 737 766	Quality of Life Questionnaire
T6	outcome-Measure 778 796	Sleep disturbances
T7	outcome-Measure 827 860	symptoms from the irradiated area
